Simon A. Crawford
15 Innovation Walk
Clayton, VIC 3800, Australia
Clayton, VIC 3800, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stress.
Journal: Antimicrobial agents and chemotherapy
Published: November 12, 2025
Pathogen species and capsule expression shape opportunistic transfer and the recipient response during plasmid RP4 conjugation.
Journal: Communications biology
Published: November 10, 2025
Asymmetric nanocapsules via elongated liposome templated polymerization (ELTP) mediated by RAFT polymerization.
Journal: Drug delivery and translational research
Published: January 19, 2025
Metabolic profiling unveils enhanced antibacterial synergy of polymyxin B and teixobactin against multi-drug resistant Acinetobacter baumannii.
Journal: Scientific reports
Published: August 02, 2024
Cardiac-targeted delivery of a novel Drp1 inhibitor for acute cardioprotection.
Journal: Journal of molecular and cellular cardiology plus
Published: July 01, 2024
Mitochondrial damage in muscle specific PolG mutant mice activates the integrated stress response and disrupts the mitochondrial folate cycle.
Journal: Nature communications
Published: June 23, 2024
Studying the photothermal activation of polydopamine-shelled, phase-change emulsion droplets into microbubbles using small- and ultra-small-angle neutron scattering.
Journal: Journal of colloid and interface science
Published: November 13, 2023
Mitochondrial abnormalities contribute to muscle weakness in a Dnajb6 deficient zebrafish model.
Journal: Human molecular genetics
Published: October 30, 2023
Removal of the endothelial surface layer via hyaluronidase does not modulate monocyte and neutrophil interactions with the glomerular endothelium.
Journal: Microcirculation (New York, N.Y. : 1994)
Published: May 25, 2023
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
Journal: Kidney international
Published: February 15, 2023
Last Updated: 09/26/2026